NASDAQ:VIVO
Delisted
Meridian Bioscience Inc. Stock News
$33.97
+0 (+0%)
At Close: Apr 28, 2023
Meridian Bioscience Participates in Piper Sandler 33rd Annual Virtual Healthcare Conference
07:05pm, Thursday, 18'th Nov 2021 Business Insider Markets
CINCINNATI, Nov. 18, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today its participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference on December 1 st and 2 nd , 2021.
Meridian Bioscience, Inc. (NASDAQ:VIVO) Shares Sold by AQR Capital Management LLC
12:16pm, Wednesday, 17'th Nov 2021 Transcript Daily
AQR Capital Management LLC decreased its position in shares of Meridian Bioscience, Inc. (NASDAQ:VIVO) by 34.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,357 shares of the company’s stock after selling 29,569 shares during the period. AQR Capital […]
Meridian Bioscience (NASDAQ:VIVO) Releases FY 2022 Earnings Guidance
01:18pm, Sunday, 14'th Nov 2021 Dakota Financial News
Meridian Bioscience (NASDAQ:VIVO) updated its FY 2022 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $0.980-$1.080 for the period, compared to the Thomson Reuters consensus estimate of $1.070. The company issued revenue guidance of $285 million-$300 million, compared to the consensus revenue estimate of $283.27 million. Several research firms recently []
Meridian Bioscience (NASDAQ:VIVO) Posts Earnings Results, Beats Expectations By $0.02 EPS
12:32pm, Sunday, 14'th Nov 2021 Dakota Financial News
Meridian Bioscience (NASDAQ:VIVO) issued its earnings results on Friday. The company reported $0.23 earnings per share (EPS) for the quarter, beating the Zacks consensus estimate of $0.21 by $0.02, MarketWatch Earnings reports. Meridian Bioscience had a net margin of 23.29% and a return on equity of 24.58%. During the same quarter last year, the company []
Meridian Bioscience, Inc. (VIVO) CEO Jack Kenny on Q4 2021 Earnings Conference Call - Earnings Call Transcript
01:26pm, Friday, 12'th Nov 2021
Meridian Bioscience, Inc. (VIVO) CEO Jack Kenny on Q4 2021 Earnings Conference Call - Earnings Call Transcript
Meridian Bioscience's Q4 Earnings Beat Expectations
11:45am, Friday, 12'th Nov 2021
Meridian Bioscience Inc (NASDAQ: VIVO) posted Q4 sales of $76.2 million, up 19% Y/Y, beating the consensus of $68.40 million. Diagnostics segment net revenues increased 15% Y/Y to $34.3 million, led
Meridian Bioscience (VIVO) Earnings Expected to Grow: Should You Buy?
04:48pm, Friday, 05'th Nov 2021
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Meridian Bioscience to Hold Fourth Quarter and Full Year 2021 Financial Results Conference Call on November 12, 2021
02:05pm, Thursday, 14'th Oct 2021
CINCINNATI, Oct. 14, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, will report fourth quarte
Meridian Launches New Air-Dryable™ qPCR Mix Enabling Direct Detection of RNA from Whole Blood Samples
02:00pm, Thursday, 07'th Oct 2021
CINCINNATI, Oct. 7, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch
Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Stool Samples
10:00am, Thursday, 09'th Sep 2021
CINCINNATI, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the addition of two
Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Saliva Samples
10:00am, Tuesday, 07'th Sep 2021
CINCINNATI, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its ne
Meridian Bioscience, Inc.: Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare Test Kits
04:30pm, Wednesday, 01'st Sep 2021
CINCINNATI, OH / ACCESSWIRE / September 1, 2021 / Meridian Bioscience, Inc. (NASDAQ:VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned s
Got $1,000? These 2 Bargain-Bin Biopharma Stocks Might Be Worth Buying
10:15am, Friday, 27'th Aug 2021
These healthcare stocks have their warts, but the price is right for long-term investors.
Meridian Bioscience, Inc. (VIVO) CEO John Kenny on Q3 2021 Results - Earnings Call Transcript
03:02pm, Friday, 06'th Aug 2021
Meridian Bioscience, Inc. (VIVO) CEO John Kenny on Q3 2021 Results - Earnings Call Transcript
Meridian Bioscience (VIVO) Q3 Earnings and Revenues Miss Estimates
10:44am, Friday, 06'th Aug 2021
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of -29.03% and -13.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?